TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biolink Group AS
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
92
|
160
|
477 |
| Financial expenses |
150
|
142
|
117 |
| Earnings before taxes |
-811
|
-1,021
|
-1,139 |
| Total assets |
6,186
|
6,383
|
7,966 |
| Current assets |
651
|
863
|
2,436 |
| Current liabilities |
661
|
321
|
347 |
| Equity capital |
3,060
|
3,740
|
5,020 |
| - share capital |
506
|
533
|
569 |
| Employees (average) | 4 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
49.5%
|
58.6%
|
63.0% |
| Turnover per employee | 23 | ||
| Profit as a percentage of turnover |
-881.5%
|
-638.1%
|
-238.8% |
| Return on assets (ROA) |
-10.7%
|
-13.8%
|
-12.8% |
| Current ratio |
98.5%
|
268.8%
|
702.0% |
| Return on equity (ROE) |
-26.5%
|
-27.3%
|
-22.7% |
| Change turnover |
-60
|
-286
|
-58 |
| Change turnover % |
-39%
|
-64%
|
-11% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.